Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data GoPro, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
1,185
1,180
1,148
1,195
892
1,161
1,094
1,005
801
652
Cost of revenue
724
795
787
782
577
684
687
682
530
432
Gross profit
462
385
361
413
315
477
407
324
271
219
Research and development
359
229
167
143
132
141
140
166
186
127
Selling and marketing
369
237
222
206
151
157
167
170
161
101
General and administrative
107
82.1
66
65.8
68.4
65.7
61
63.8
59.8
56.4
Operating expenses
835
548
455
415
351
364
368
399
406
303
Operating income
-373
-163
-94
-2.33
-36.8
113
39
-75.5
-135
-83.3
Interest expense
2.99
13.7
18.7
19.2
20.3
22.9
6.24
4.7
3.33
Interest income
3.1
9.9
4.7
3.1
Other non-operating income
-2.21
-12.9
-13.7
-16.7
-25.1
-23.1
-4.5
7.73
1.94
-8.11
Pre-tax income
-375
-176
-108
-19.1
-62
90.1
34.5
-67.7
-133
-91.4
Income tax
43.8
6.49
1.36
-4.43
4.83
-281
5.61
-14.6
299
2.04
Net income
-419
-183
-109
-14.6
-66.8
371
28.8
-53.2
-432
-93.5
EBITDA
-331
-122
-58.9
23.9
-17.8
124
47.5
-69.3
-129
-76.3
EPS, basic
-3.01
-1.32
-0.78
-0.10
-0.45
2.41
0.18
-0.35
-2.82
EPS, diluted
-3.01
-1.32
-0.78
-0.10
-0.45
2.27
0.18
-0.35
-2.82
-0.59
Shares, basic (weighted)
139
138
139
145
149
154
156
153
153
Shares, diluted (weighted)
139
138
139
145
149
163
178
153
153
159
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
192
203
152
150
326
401
224
223
103
49.7
Short-term investments
25.8
44.9
45.4
14.8
0
138
144
23.9
0
Receivables
165
113
129
201
107
114
77
91.5
85.9
93.5
Inventory
167
151
116
144
97.9
86.4
127
106
121
78.4
Other current assets
38.1
62.8
30.9
26
23.9
42.3
34.6
38.3
29.8
31
Total current assets
588
574
474
536
557
782
606
483
339
253
Property, plant and equipment
76.5
68.6
46.6
36.5
23.7
19
13.3
8.69
8.7
5.9
Lease right-of-use assets
0
53.1
31.6
27.3
21.8
18.7
14.4
11.1
Goodwill
146
146
146
146
146
146
146
146
152
134
Intangible assets
33.5
24.5
13.1
5.25
1.21
0.06
0.02
0.02
5.95
4.08
Other non-current assets
78.3
37
18.2
15.5
11.8
285
289
311
29
24.6
Total assets
923
850
698
793
771
1,260
1,077
968
544
428
Accounts payable
205
138
148
161
111
172
91.6
103
85.9
97
Accrued liabilities
211
213
136
142
114
129
119
110
111
95.9
Deferred revenue
14.4
19.2
15.1
15.5
28.1
42.5
55.9
55.9
55.4
52.6
Short-term debt
122
93.2
19.6
Total current liabilities
431
371
299
327
263
475
276
279
356
277
Lease liabilities
0
63
52
43
33.4
25.5
18.1
7.33
Other non-current liabilities
18.6
29.8
28.2
6.73
4.43
7.5
5.44
3.67
6.03
9.07
Total liabilities
476
552
486
559
555
644
465
412
392
351
Total debt
0
130
139
149
218
111
141
92.6
0
44.3
Paid-in capital
757
854
895
931
980
1,009
961
998
1,027
1,045
Retained earnings
-275
-442
-569
-584
-651
-279
-196
-249
-682
-775
Treasury stock
-35.6
-114
-114
-114
-114
-114
-153
-193
-193
-193
Shareholders' equity
447
299
212
234
216
616
612
556
152
76.6
Total equity
447
299
212
234
216
616
612
556
152
76.6
Total liabilities and equity
923
850
698
793
771
1,260
1,077
968
544
428
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-419
-183
-109
-14.6
-66.8
371
28.8
-53.2
-432
-93.5
Depreciation and amortization
41.6
41.5
35.1
26.3
19.1
11
8.57
6.16
6.49
7.07
Stock-based compensation
69.5
51.3
40.9
37.2
30
38.7
39
41.5
29.1
19.5
Deferred income tax
38.6
-2.53
-0.39
-0.03
-0.05
-274
2.71
-17.9
297
0.28
Change in receivables
-18.8
52.3
-16.5
-71.3
93.1
-8.14
37.8
-14.5
5.29
-7.3
Change in inventory
21
16.6
34.1
-27.8
46.3
11.5
-40.7
20.9
-14.5
42.3
Change in payables
143
-44.4
-70.4
3.21
-87.5
56.3
-97.1
-4.23
-21.2
-11.1
Cash from operations
-108
-36.9
-42.4
-24.4
93.8
229
5.75
-32.9
-125
-20.7
Capital expenditures
-43.6
-24.1
-11
-8.35
-4.88
-5.55
-3.45
-1.52
-4.04
-3.36
Acquisitions
-104
0
0
0
0
-12.3
0
Purchases of investments
0
-52.3
-57.7
-43.6
0
-147
-166
-25.8
0
0
Sales and maturities of investments
120
21.7
57.5
56.9
14.8
8.34
161
149
24
0
Cash from investing
19.3
-43.1
-6.24
22.8
9.51
-144
-8.39
122
7.65
-3.36
Debt issued
0
0
144
0
0
Stock issued
9.66
9.75
5.17
5.57
5.44
7.49
4.76
3.88
2.15
2.71
Share buybacks
0
-78
0
0
-39.6
-40
0
0
Cash from financing
1.96
88.6
-1.48
-1.04
72
-9.89
-173
-90.4
-0.93
-30.1
Exchange rate effect
-1.05
1.75
-0.26
0.92
2.08
-2.11
-1.44
0.32
-1.48
1.01
Net change in cash
-87.6
10.4
-50.4
-1.79
177
73.4
-177
-1.03
-120
-53.1
Free cash flow
-151
-60.9
-53.4
-32.8
88.9
224
2.3
-34.4
-129
-24
Interest paid
0
3.11
6.13
6.18
6.72
6.13
4.26
1.98
1.29
4.31
Income taxes paid
9.69
8.37
-32.1
0.18
2.24
0.81
2.1
-0.54
1.09
0.85
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.29 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
27.7%
Gross profit / revenue.
Operating margin
-21.2%
Operating income / revenue.
EBITDA margin
-20.1%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-28.2%
Pre-tax income / revenue.
Net margin
-28.5%
Net income / revenue.
FCF margin
-4.1%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-3.5%
Cash from operations / revenue.
Return on assets (ROA)
-40.7%
Net income / average total assets.
R&D / revenue
22.0%
Research and development expense / revenue.
Stock-based pay / revenue
2.8%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.6%
Capital expenditures / revenue.
D&A / revenue
1.1%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-18.7%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-15.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-6.1%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-19.2%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-18.6%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-7.0%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-49.5%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-50.0%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-18.7%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-21.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-26.5%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-11.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
3.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-3.8%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
1.2%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.57x
Current assets / current liabilities.
Quick ratio
0.22x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.07x
(Cash + short-term investments) / current liabilities.
Debt / assets
0.0%
Total debt / total assets.
Liabilities / assets
108.2%
Total liabilities / total assets.
Net debt
-$27.3M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.95
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$3.32
Revenue / diluted weighted shares.
FCF per share
-$0.14
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.11
Cash from operations / diluted weighted shares.
Book value per share
-$0.19
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.42x
Market cap / revenue.
EV/Sales
0.37x
Enterprise value / revenue.
FCF yield
-9.8%
Free cash flow / market cap.
Earnings yield
-68.1%
Net income / market cap (the inverse of P/E).
What was GoPro, Inc.'s revenue in fiscal 2025?
GoPro, Inc. reported revenue of $651.5M for fiscal 2025, 18.7% lower than the year before.
Was GoPro, Inc. profitable in fiscal 2025?
No. It reported a net loss of $93.5M.
How much free cash flow did GoPro, Inc. generate in fiscal 2025?
Cash from operations of $20.7M minus capital expenditures of $3.4M left free cash flow of -$24.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.